| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
58,625,000 |
| Market
Cap: |
1.71(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.72 - $35.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. Co.'s products include Trokendi XR and Oxtellar XR, which are the once-daily extended release topiramate and oxcarbazepine products indicated for the treatment of epilepsy; APOKYN, which is a product indicated for the intermittent treatment of hypomobility or off episodes in patients with Parkinson's Disease (PD); XADAGO, which is an once-daily product indicated as adjunctive treatment to levodopa/carbidopa in patients with PD; and MYOBLOC, which is a product indicated for the treatment of cervical dystonia and sialorrhea in adults.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
98,505 |
106,505 |
124,343 |
450,780 |
| Total Sell Value |
$3,345,846 |
$3,569,126 |
$4,091,741 |
$15,155,681 |
| Total People Sold |
1 |
2 |
5 |
6 |
| Total Sell Transactions |
6 |
7 |
11 |
37 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schwabe Stefan K.f. |
Executive Vice President R&D |
• – – |
2017-09-07 |
4 |
OE |
$12.92 |
$1,227,400 |
D/D |
95,000 |
96,855 |
|
- |
|
| Bhatt Padmanabh P. |
Sr.VP of IP, CSO |
• – – |
2017-08-16 |
4 |
AS |
$45.23 |
$167,755 |
D/D |
(3,709) |
17,500 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-07-12 |
4 |
AS |
$44.90 |
$167,702 |
D/D |
(3,735) |
21,209 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-06-23 |
4 |
AS |
$44.90 |
$114,774 |
D/D |
(2,556) |
24,944 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-06-02 |
4 |
AS |
$39.86 |
$398,558 |
D/D |
(10,000) |
27,500 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-05-26 |
4 |
AS |
$35.90 |
$89,758 |
D/D |
(2,500) |
37,500 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-05-25 |
4 |
AS |
$34.90 |
$135,656 |
D/D |
(3,887) |
40,000 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-05-24 |
4 |
AS |
$34.90 |
$56,294 |
D/D |
(1,613) |
43,887 |
|
- |
|
| Patrick Gregory S |
VP, Chief Financial Officer |
• – – |
2017-04-24 |
4 |
AS |
$32.37 |
$1,747,872 |
D/D |
(54,000) |
221 |
|
- |
|
| Patrick Gregory S |
VP, Chief Financial Officer |
• – – |
2017-04-24 |
4 |
OE |
$5.88 |
$294,000 |
D/D |
50,000 |
54,221 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2017-04-24 |
4 |
AS |
$32.59 |
$384,762 |
D/D |
(11,806) |
45,500 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2017-04-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,250) |
1,089,750 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2017-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,250 |
449,909 |
|
- |
|
| Patrick Gregory S |
VP, Chief Financial Officer |
• – – |
2016-09-16 |
4 |
AS |
$25.00 |
$50,000 |
D/D |
(2,000) |
3,616 |
|
- |
|
| Patrick Gregory S |
VP, Chief Financial Officer |
• – – |
2016-07-14 |
4 |
AS |
$22.00 |
$74,690 |
D/D |
(3,395) |
5,616 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2016-04-11 |
4 |
AS |
$16.49 |
$507,228 |
D/D |
(30,762) |
57,306 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2016-03-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,000) |
1,094,000 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2016-03-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
444,124 |
|
- |
|
| Barrett M James |
Director |
– • – |
2016-03-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,000 |
97,355 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2015-12-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,000 |
2,250 |
|
- |
|
| Khattar Jack A. |
President, CEO |
• • – |
2015-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
436,434 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2015-12-09 |
4 |
AS |
$14.90 |
$69,807 |
D/D |
(4,685) |
88,068 |
|
- |
|
| Bhatt Padmanabh P. |
Sr. VP of IP, CSO |
• – – |
2015-12-08 |
4 |
AS |
$14.90 |
$142,341 |
D/D |
(9,553) |
92,753 |
|
- |
|
| Barrett M James |
Director |
– • – |
2015-12-08 |
4 |
S |
$14.75 |
$1,045,953 |
I/I |
(70,913) |
0 |
|
- |
|
| Barrett M James |
Director |
– • – |
2015-12-07 |
4 |
S |
$14.38 |
$1,022,192 |
I/I |
(71,067) |
70,913 |
|
- |
|
385 Records found
|
|
Page 11 of 16 |
|
|
0.06 (0.21%) 
